XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (Q3)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q3)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q9)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 8.32%48.55M | -15.76%91.25M | 4.61%44.82M | 10.13%20.99M | 39.22%108.32M | 68.36%64.64M | 128.35%42.85M | 244.62%19.06M | 31.79%77.81M | -16.81%38.4M |
Operating income | 8.32%48.55M | -15.76%91.25M | 4.61%44.82M | 10.13%20.99M | 39.22%108.32M | 68.36%64.64M | 128.35%42.85M | 244.62%19.06M | 31.79%77.81M | -16.81%38.4M |
Cost of sales | -20.53%-40.7M | 18.29%-72.41M | 17.59%-33.77M | -1.24%-17.92M | -21.75%-88.61M | -70.15%-60.73M | -145.98%-40.98M | -279.85%-17.7M | -34.59%-72.79M | 16.73%-35.69M |
Operating expenses | -20.53%-40.7M | 18.29%-72.41M | 17.59%-33.77M | -1.24%-17.92M | -21.75%-88.61M | -70.15%-60.73M | -145.98%-40.98M | -279.85%-17.7M | -34.59%-72.79M | 16.73%-35.69M |
Gross profit | -28.97%7.85M | -4.38%18.85M | 491.91%11.05M | 125.37%3.07M | 292.63%19.71M | 44.64%3.91M | -11.26%1.87M | 56.42%1.36M | 1.25%5.02M | -17.73%2.71M |
Selling expenses | -64.29%-23K | 39.06%-39K | 82.28%-14K | 97.22%-1K | 87.62%-64K | 87.34%-145K | 90.37%-79K | 91.13%-36K | 61.62%-517K | -24.86%-1.15M |
Administrative expenses | 61.82%-5.17M | -121.42%-37.57M | -176.51%-13.55M | -63.42%-18.66M | 59.15%-16.97M | -23.33%-42.36M | 77.99%-4.9M | -25.59%-11.42M | -18.31%-41.54M | -161.67%-34.34M |
Impairment and provision | --3.18M | -486.86%-23.8M | ---- | ---- | -167.37%-4.06M | ---- | ---- | ---- | ---1.52M | ---- |
-Other impairment is provision | --3.18M | -486.86%-23.8M | ---- | ---- | -167.37%-4.06M | ---- | ---- | ---- | ---1.52M | ---- |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | -26.23%-77K | ---- | ---- | ---- | 71.23%-61K |
Special items of operating profit | 111.53%102K | 7.45%-8.49M | 69.26%-885K | -372.46%-455K | -21.87%-9.17M | 41.03%-3.16M | 41.61%-2.88M | 22.79%167K | -17.26%-7.53M | -696.11%-5.37M |
Operating profit | 274.65%5.93M | -383.96%-51.05M | 43.30%-3.4M | -61.66%-16.05M | 77.11%-10.55M | -9.47%-41.83M | 76.92%-5.99M | -16.39%-9.93M | -20.75%-46.08M | -279.62%-38.21M |
Financing cost | -13.18%-249K | -374.51%-484K | -348.98%-220K | 83.57%-80K | -30.77%-102K | ---- | ---49K | ---487K | ---78K | ---- |
Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 39.46%417K |
Earning before tax | 257.15%5.68M | -383.87%-51.54M | 40.12%-3.62M | -54.86%-16.13M | 76.92%-10.65M | -10.68%-41.83M | 76.36%-6.04M | -24.77%-10.41M | -20.58%-46.15M | -365.76%-37.79M |
Tax | -72.30%-1.42M | -119.80%-3.05M | ---823K | ---- | ---1.39M | ---- | ---- | ---- | ---- | ---- |
After-tax profit from continuing operations | 196.08%4.27M | -353.41%-54.59M | 26.49%-4.44M | -54.86%-16.13M | 73.91%-12.04M | -10.68%-41.83M | 76.36%-6.04M | -24.77%-10.41M | -20.58%-46.15M | -365.76%-37.79M |
After-tax profit from non-continuing business | ---- | 31.39%-21.51M | 6.88%-21.22M | ---- | ---31.35M | ---- | ---22.78M | ---- | ---- | ---- |
Earning after tax | 116.63%4.27M | -75.39%-76.1M | 10.99%-25.66M | -54.86%-16.13M | 6.00%-43.39M | -10.68%-41.83M | -12.82%-28.82M | -24.77%-10.41M | -17.91%-46.15M | -156.37%-37.79M |
Minority shareholders should account for non-continuing business profits | ---- | ---- | -11.86%-7.07M | ---- | ---- | ---- | ---6.32M | ---- | ---- | ---- |
Minority profit | ---- | 32.33%-7.17M | -11.86%-7.07M | -58.86%-4.46M | -19.95%-10.59M | 24.91%-6.32M | -20.56%-6.32M | -46.58%-2.81M | -562.89%-8.83M | -147.25%-8.42M |
Shareholders should account for profits from continuing business | 196.08%4.27M | -353.41%-54.59M | 26.49%-4.44M | ---- | ---12.04M | ---- | ---6.04M | ---- | ---- | ---- |
Shareholders should account for profits from non-continuing business | ---- | 30.92%-14.34M | 14.08%-14.14M | ---- | ---20.75M | ---- | ---16.46M | ---- | ---- | ---- |
Profit attributable to shareholders | 122.96%4.27M | -110.19%-68.93M | 17.41%-18.58M | -53.39%-11.66M | 12.14%-32.79M | -20.88%-35.51M | -10.82%-22.5M | -18.26%-7.6M | 9.09%-37.32M | -159.11%-29.37M |
Basic earnings per share | 122.66%0.0029 | -110.22%-0.0473 | 16.88%-0.0128 | -53.85%-0.008 | 12.11%-0.0225 | -20.79%-0.0244 | -10.79%-0.0154 | -18.18%-0.0052 | 9.22%-0.0256 | -158.97%-0.0202 |
Diluted earnings per share | 122.66%0.0029 | -110.22%-0.0473 | 16.88%-0.0128 | -53.85%-0.008 | 12.11%-0.0225 | -20.79%-0.0244 | -10.79%-0.0154 | -18.18%-0.0052 | 9.22%-0.0256 | -158.97%-0.0202 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | -- | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.